Cellular and humoral immunity following two AZD1222 and two booster vaccinations in hemodialysis patients
Two AZD1222 and two mRNA booster doses confer substantial humoral and cellular immunity against variants including omicron in hemodialysis patients.
Authors
- Yu‐Tzu Chang (ORCID: https://orcid.org/0000-0003-1449-9431)
- Chiao-Hsuan Chao (ORCID: https://orcid.org/0000-0003-0114-0948)
- Jia‐Ling Wu (ORCID: https://orcid.org/0000-0002-7785-9134)
- Wen‐Chien Ko (ORCID: https://orcid.org/0000-0001-7497-149X)
- Chi‐Chang Shieh (ORCID: https://orcid.org/0000-0002-8245-9602)
- Tsai‐Chieh Ling (ORCID: https://orcid.org/0000-0002-6796-2437)
- Chieh‐Hsin Huang (ORCID: https://orcid.org/0009-0002-9848-2185)
- Chien‐Yao Sun (ORCID: https://orcid.org/0000-0001-6236-6022)
- Jen‐Ren Wang (ORCID: https://orcid.org/0000-0002-4127-4046)
- Po‐Lin Chen (ORCID: https://orcid.org/0000-0002-4015-1052)
- Wei-Ren Lin
Institutions
- National Health Research Institutes (TW)
- Mackay Medical University (TW)
- National Cheng Kung University Hospital (TW)
- National Cheng Kung University (TW)
Publication Details
- Journal
- Journal of Microbiology Immunology and Infection
- Published
- 2025-08-27
- DOI
- https://doi.org/10.1016/j.jmii.2025.08.014
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Cheng Kung University Hospital